IceCure Medical (ICCM) Change in Accured Expenses (2021 - 2026)
IceCure Medical's (ICCM) quarterly Change in Accured Expenses came in at -$311000.0 in Q1 2026, up 7.44% year-on-year from -$289462.6 in Q1 2025, and up 34.94% on a QoQ basis from -$478000.0 in Q4 2025.
IceCure Medical (ICCM) Change in Accured Expenses (2021 - 2026) Analysis & Trends
IceCure Medical (ICCM) has 6 years of Change in Accured Expenses data on file, last reported at -$311000.0 in Q1 2026.
- On a quarterly basis, Change in Accured Expenses rose 7.44% year-over-year to -$311000.0 in Q1 2026; TTM through Mar 2026 was -$104000.0, a 68.1% increase from a year earlier, with the FY2025 full-year figure at -$129000.0, down 274.32% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$311000.0, up from -$478000.0 in the prior quarter.
- Over the last five years, Change in Accured Expenses for ICCM reached as high as $1.1 million in Q1 2022 and fell as low as -$852000.0 in Q2 2022.
- Historically, Change in Accured Expenses has averaged $32866.7 across 5 years, with a median of -$15000.0 in 2022.
- Across the five-year window, Change in Accured Expenses surged 2826.67% in 2023 and sank 625.0% in 2025, its largest moves.
- Year by year, Change in Accured Expenses stood at -$15000.0 in 2022, then jumped by 2826.67% to $409000.0 in 2023, then sank by 164.3% to -$263000.0 in 2024, then plunged by 81.75% to -$478000.0 in 2025, then jumped by 34.94% to -$311000.0 in 2026.
- Per Business Quant data, the three most recent Change in Accured Expenses figures were -$311000.0 in Q1 2026, -$478000.0 in Q4 2025, and $166000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | IceCure Medical | 7.92 Mn | -193,612.29 | 295,000.00 | -311,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -311,000.00 |
| Mar 31, 2026 | -311,000.00 |
| Dec 31, 2025 | -478,000.00 |
| Dec 31, 2025 | -478,000.00 |
| Sep 30, 2025 | 166,000.00 |
| Sep 30, 2025 | 166,000.00 |
| Jun 30, 2025 | 519,000.00 |
| Jun 30, 2025 | 519,000.00 |
| Mar 31, 2025 | -336,000.00 |
| Mar 31, 2025 | -336,000.00 |
| Dec 31, 2024 | -263,000.00 |
| Dec 31, 2024 | -263,000.00 |
| Sep 30, 2024 | -51,000.00 |
| Sep 30, 2024 | -51,000.00 |
| Jun 30, 2024 | 324,000.00 |
| Jun 30, 2024 | 324,000.00 |
| Mar 31, 2024 | 64,000.00 |
| Mar 31, 2024 | 64,000.00 |
| Dec 31, 2023 | 409,000.00 |
| Dec 31, 2023 | 409,000.00 |